RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Pentwater Capital Management LP's Holding History (CIK: 0001425851)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 100,000 Value ($000) $986 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 100,000 Value ($000) $765 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 365,000 Value ($000) $2,727 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 420,000 Value ($000) $2,801 Avg Close $7.93 Range $6.40 - $9.73
Q4 2022
Shares 400,000 Value ($000) $3,084 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 300,000 Value ($000) $3,192 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 300,000 Value ($000) $2,442 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 300,000 Value ($000) $2,148 Avg Close $10.63 Range $5.80 - $18.23
Q4 2021
Shares 280,000 Value ($000) $4,796 Avg Close $18.82 Range $15.25 - $23.86
Q3 2021
Shares 265,000 Value ($000) $6,098 Avg Close $28.34 Range $17.80 - $42.81
Q2 2021
Shares 252,500 Value ($000) $9,216 Avg Close $29.60 Range $19.68 - $38.39